Am I the only one tired of the online cultural wars and all those labels thown around? Do they still mean anything?

Good ideas but Lea, please! Your conversations are too academic as if you're addressing MA graduates. We don't need that on a podcast.

Son genéricos. No hay dinero en estos fármacos.

Where was it published?

El síndrome cardiorenal es una categoría más bien patofisiológica que clínica. Despesa la prospectiva clínicos es insuficiencia cardíaca +/- ER. Mucho interés últimamente empujado por los fabricantes de #sglt2i y #GLP1.

I agree. Can't make conclusions out of these studies. But if you play chances your best bet would be apixaban .

There are observational studies and metanalysis. No head-to-head RCTs. In Spain apixaban is the most widely used. I guess in many countries as well .

It is not just a dosing issue. Dabigatran is significantly different deo apixaban. The latter being the most used in practice. The comprarlo VKA with hodgepodge of DOAC.